Variation Biotechnologies' Acquisition

Variation Biotechnologies was acquired by Paulson Investment Company on May 09, 2014.

Variation Biotechnologies is a vaccine company which leverages bioinformatics to develop synthetic vaccines against highly variant pathogens. VBI's approach to vaccine development and growing pipeline…

Articles about Variation Biotechnologies' Acquisition: